Department of Cardiology, Heart Failure Research Centre, Academic Medical Centre, Meibergdreef 9, 1105AZ Amsterdam, Netherlands.
Pediatrics. 2011 Jan;127(1):e239-44. doi: 10.1542/peds.2010-1688. Epub 2010 Dec 6.
Cardiac channelopathies caused by SCN5A mutation are well tolerated by most patients. However, the dramatic presentation of a previously healthy 4-month-old girl with life-threatening arrhythmias and the subsequent findings in the child and her family provide evidence that loss-of-function sodium channel mutations can present very early in life. An SCN5A mutation was detected in the infant, her brother, and their father. Both the siblings manifested recurrent serious arrhythmias during febrile episodes, which followed immunization, as well as fever of nonspecific origin. Management consisted of prompt antipyretic measures, hospitalization with vigorous monitoring during immunization and febrile episodes, and prevention of tachycardia-induced conduction disturbance with β-blockers.
由 SCN5A 突变引起的心脏通道病在大多数患者中耐受性良好。然而,一名此前健康的 4 个月大女婴出现危及生命的心律失常,且该患儿及其家族的后续检查结果表明,失活钠离子通道突变可在生命早期出现。该婴儿、其哥哥及其父亲均检测出 SCN5A 突变。姐弟俩在发热时均反复出现严重心律失常,这些发热与免疫接种有关,也有非特异性发热。治疗包括退热措施、免疫接种和发热期间的强化监测、β受体阻滞剂预防心动过速引起的传导障碍。